Related Experiment Video

Updated: Jun 17, 2025

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

3.5K

Bioconjugates for Cancer Prevention: Opportunities for Impact

Erin Lavik1, Lori Minasian1

  • 1Division of Cancer Prevention, National Cancer Institute, 9609 Medical Center Dr, Rockville, Maryland 20850, United States.

Bioconjugate Chemistry
|August 8, 2024
PubMed

Insights

Bioconjugates, materials with synthetic and biological parts, show promise for cancer prevention. These innovative tools can improve early cancer screening and reduce cancer risk through vaccines and drugs.

Area of Science:

  • Bioconjugate chemistry
  • Cancer research
  • Preventive medicine

Background:

  • Cancer prevention involves early detection (screening) and risk reduction (prevention/interception).
  • Bioconjugates, defined as materials with synthetic and biological components, are emerging as versatile tools.
  • These materials offer potential across the entire cancer prevention spectrum.

Purpose of the Study:

  • To explore the role of bioconjugates in cancer prevention strategies.
  • To highlight the potential of bioconjugates in improving cancer screening accessibility and effectiveness.
  • To discuss the application of bioconjugates in developing novel vaccines and drugs for cancer risk reduction.

Main Methods:

  • Literature review on bioconjugate applications in cancer prevention.
  • Analysis of developmental programs for novel cancer prevention technologies.
  • Discussion of challenges and opportunities in implementing bioconjugate-based interventions.

Main Results:

  • Bioconjugates can be developed as affordable and accessible screening tools.
  • Bioconjugates show potential as novel vaccines and drugs to lower cancer risk.
  • Existing developmental programs can evaluate bioconjugate technologies for clinical use.

Conclusions:

  • Bioconjugates offer a promising avenue for advancing cancer screening and prevention.
  • Thoughtful development of bioconjugates can enhance the delivery and acceptance of cancer interventions.
  • Further research and development are needed to fully realize the potential of bioconjugates in combating cancer.

More Related Videos

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

7.6K
In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research08:53

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

8.9K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
497
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K